|
MGVS develops
therapeutic
products that address heart and blood vessel disorders.
Our products uniquely target “no option patients”
who cannot be treated adequately with current therapeutic modalities. |
|
 MultiGene
Angio:
A cell therapy
product for alleviating symptoms and signs of ischemia
in patients
with peripheral arterial disease (PAD)
and coronary artery disease (CAD).
|
MultiGene
Graft:
A biosynthetic vascular graft providing improved biocompatibility for renal disease patients who need an access site for hemodialysis.
|
|
|
|
